LIZHI INC (LIZI) Stock Fundamental Analysis

NASDAQ:LIZI • US53933L2034

2.8 USD
+0.06 (+2.19%)
At close: Jan 24, 2024
2.89 USD
+0.09 (+3.21%)
After Hours: 1/24/2024, 8:00:03 PM
Fundamental Rating

5

Taking everything into account, LIZI scores 5 out of 10 in our fundamental rating. LIZI was compared to 80 industry peers in the Entertainment industry. LIZI has only an average score on both its financial health and profitability. LIZI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, LIZI could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • LIZI had positive earnings in the past year.
LIZI Yearly Net Income VS EBIT VS OCF VS FCFLIZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • LIZI has a Return On Assets of 14.87%. This is amongst the best in the industry. LIZI outperforms 97.26% of its industry peers.
  • With an excellent Return On Equity value of 23.66%, LIZI belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 14.23%, LIZI belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROIC 14.23%
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIZI Yearly ROA, ROE, ROICLIZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 -500 1K 1.5K 2K

1.3 Margins

  • The Profit Margin of LIZI (4.79%) is better than 80.82% of its industry peers.
  • LIZI has a Operating Margin of 3.72%. This is in the better half of the industry: LIZI outperforms 65.75% of its industry peers.
  • LIZI has a Gross Margin (31.28%) which is in line with its industry peers.
  • LIZI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
LIZI Yearly Profit, Operating, Gross MarginsLIZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60 -80

5

2. Health

2.1 Basic Checks

  • LIZI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • LIZI has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for LIZI has been reduced compared to a year ago.
LIZI Yearly Shares OutstandingLIZI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
LIZI Yearly Total Debt VS Total AssetsLIZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 0.35, we must say that LIZI is in the distress zone and has some risk of bankruptcy.
  • LIZI has a Altman-Z score of 0.35. This is comparable to the rest of the industry: LIZI outperforms 46.58% of its industry peers.
  • LIZI has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.01, LIZI is in the better half of the industry, outperforming 78.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACC1.94
WACC7.35%
LIZI Yearly LT Debt VS Equity VS FCFLIZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M

2.3 Liquidity

  • LIZI has a Current Ratio of 2.58. This indicates that LIZI is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.58, LIZI belongs to the best of the industry, outperforming 80.82% of the companies in the same industry.
  • A Quick Ratio of 2.58 indicates that LIZI has no problem at all paying its short term obligations.
  • LIZI's Quick ratio of 2.58 is amongst the best of the industry. LIZI outperforms 80.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.58
LIZI Yearly Current Assets VS Current LiabilitesLIZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 200M 400M 600M

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1683.33% over the past year.
  • Looking at the last year, LIZI shows a quite strong growth in Revenue. The Revenue has grown by 13.31% in the last year.
  • LIZI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.96% yearly.
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%

3.2 Future

  • Based on estimates for the next years, LIZI will show a very negative growth in Earnings Per Share. The EPS will decrease by -48.05% on average per year.
  • Based on estimates for the next years, LIZI will show a very strong growth in Revenue. The Revenue will grow by 114.98% on average per year.
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LIZI Yearly Revenue VS EstimatesLIZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
LIZI Yearly EPS VS EstimatesLIZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

5

4. Valuation

4.1 Price/Earnings Ratio

  • LIZI is valuated cheaply with a Price/Earnings ratio of 0.92.
  • Based on the Price/Earnings ratio, LIZI is valued cheaper than 100.00% of the companies in the same industry.
  • LIZI is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 10.34, which indicates a very decent valuation of LIZI.
  • Based on the Price/Forward Earnings ratio, LIZI is valued cheaper than 89.04% of the companies in the same industry.
  • LIZI is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
LIZI Price Earnings VS Forward Price EarningsLIZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.38
LIZI Per share dataLIZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as LIZI's earnings are expected to decrease with -48.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%

0

5. Dividend

5.1 Amount

  • No dividends for LIZI!.
Industry RankSector Rank
Dividend Yield N/A

LIZHI INC

NASDAQ:LIZI (1/24/2024, 8:00:03 PM)

After market: 2.89 +0.09 (+3.21%)

2.8

+0.06 (+2.19%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-14
Earnings (Next)03-14
Inst Owners1.35%
Inst Owner Change-32.06%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.82M
Revenue(TTM)2.38B
Net Income(TTM)113.80M
Analysts85.71
Price Target1.43 (-48.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA -5.38
EPS(TTM)3.04
EY108.57%
EPS(NY)0.27
Fwd EY9.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS62.58
BVpS12.66
TBVpS12.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROCE 18.29%
ROIC 14.23%
ROICexc N/A
ROICexgc N/A
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
FCFM N/A
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
F-ScoreN/A
Asset Turnover3.11
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.58
Altman-Z 0.35
F-ScoreN/A
WACC7.35%
ROIC/WACC1.94
Cap/Depr(3y)93.44%
Cap/Depr(5y)138.6%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A
EBIT growth 1Y1575%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-82.2%
EBIT Next 3Y15.08%
EBIT Next 5YN/A
FCF growth 1Y303.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y437.38%
OCF growth 3YN/A
OCF growth 5YN/A

LIZHI INC / LIZI FAQ

What is the fundamental rating for LIZI stock?

ChartMill assigns a fundamental rating of 5 / 10 to LIZI.


What is the valuation status of LIZHI INC (LIZI) stock?

ChartMill assigns a valuation rating of 5 / 10 to LIZHI INC (LIZI). This can be considered as Fairly Valued.


How profitable is LIZHI INC (LIZI) stock?

LIZHI INC (LIZI) has a profitability rating of 5 / 10.


Can you provide the financial health for LIZI stock?

The financial health rating of LIZHI INC (LIZI) is 5 / 10.